Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

Geron Corporation (GERN)

-NasdaqGS
1.94 0.03(1.52%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Prev Close:1.97
Open:1.97
Bid:N/A
Ask:2.02 x 20000
1y Target Est:2.00
Beta:2.46
Earnings Date:Apr 28 - May 2 (Est.)
Day's Range:1.91 - 2.02
52wk Range:1.03 - 7.79
Volume:2,393,706
Avg Vol (3m):6,510,500
Market Cap:304.38M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GERN

Comparison

Symbol% ChgMkt Cap
GERNDown 1.52%304.38M
BMY81.62B
GSK125.79B
NVS205.42B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):240.91
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.26
Quarterly EPS Est (Mar-14) :-0.06
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):-1.49

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback